Agriculture & Agritech Global On demand · 24-48h

Global Poultry Gut Health Solutions Market Strategic Research Report

Global Poultry Gut Health Solutions Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Poultry Gut Health Solutions Market
$5.49B2025
8.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Probiotics and Prebiotics, Enzymes, Organic Acids, Phytogenics, Others

By Application: Broilers, Breeders and Layers, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Evonik, Trouw Nutrition, DSM, Alltech, Novonesis, Bluestar Adisseo, Eastman, Cargill, Kemin Industries, Perstorp, Novus International, Orffa, Merck Animal Health, Danisco Animal Nutrition & Health (IFF), Lallemand, EW Nutrition, Balchem, Impextraco, Alivira Animal Health, Biochem, Biorigin, Asahi Biocycle, Amlan International, AB Vista, Lesaffre

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 156 pages
Market size 2025
$5.49B
Billion USD
Forecast CAGR
8.7%
2025-2032
Forecast 2032
$9.8B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Poultry Gut Health Solutions market size is predicted to grow from US$ 5,491 million in 2025 to US$ 9,754 million in 2032; it is expected to grow at a CAGR of 8.7% from 2026 to 2032.

Poultry Gut Health Solutions refer to a set of products, techniques, and management practices aimed at promoting and maintaining the health and functionality of the gastrointestinal (GI) tract in poultry, such as chickens, turkeys, and ducks. These solutions are crucial for enhancing digestion, nutrient absorption, immune function, and overall growth performance in poultry. These solutions are designed to reduce the occurrence of digestive disorders, improve feed efficiency, enhance immune response, and reduce the need for antibiotics, contributing to healthier, more productive poultry.

In recent years, the poultry industry has experienced significant changes driven by genetic improvements in poultry breeds and fluctuations in feed ingredient prices. Enhanced genetic traits in commercial broilers and layers have increased the need for improved nutrition and management practices to maximize performance. At the same time, the cost of essential feed ingredients like corn and soybean meal has risen substantially, creating a need for more efficient nutrient utilization. These factors, coupled with shifting consumer preferences and stricter regulations, have driven three major trends in the poultry sector: Antibiotic Reduction (ABR), Cage-Free production, and Food Safety. As concerns over antibiotic resistance intensify, the global demand for antibiotic-free (ABF) meat has surged, especially in the U.S., where over 50% of chicken production now follows the “no antibiotics ever” (NAE) program. However, the transition to ABF production poses challenges, primarily due to increased gut health issues that can negatively impact poultry performance. The prevention of conditions like coccidiosis and necrotic enteritis has become critical. To address these challenges, poultry producers are turning to innovative gut health solutions, including dietary fiber, probiotics, prebiotics, feed enzymes, and organic acids, to support gut health and improve overall flock productivity, welfare, and food safety.

This report presents a comprehensive overview of the global Poultry Gut Health Solutions market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Probiotics and Prebiotics
  • Enzymes
  • Organic Acids
  • Phytogenics
  • Others

Segment by players, this report covers

  • Evonik
  • Trouw Nutrition
  • DSM
  • Alltech
  • Novonesis
  • Bluestar Adisseo
  • Eastman
  • Cargill
  • Kemin Industries
  • Perstorp
  • Novus International
  • Orffa
  • Merck Animal Health
  • Danisco Animal Nutrition & Health (IFF)
  • Lallemand
  • EW Nutrition
  • Balchem
  • Impextraco
  • Alivira Animal Health
  • Biochem
  • Biorigin
  • Asahi Biocycle
  • Amlan International
  • AB Vista
  • Lesaffre

Segment by Application

  • Broilers
  • Breeders and Layers
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Poultry Gut Health Solutions market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Broilers, Breeders and Layers, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Poultry Gut Health Solutions Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.49B
2025
Forecast
$9.8B
2032
CAGR
8.7%
2025–2032
Regionen
5
global
Key companies
EvonikTrouw NutritionDSMAlltechNovonesisBluestar AdisseoEastmanCargill
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Probiotics and PrebioticsEnzymesOrganic AcidsPhytogenicsOthers
By Application
BroilersBreeders and LayersOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Probiotics and Prebiotics
  • 3.1.3 Enzymes
  • 3.1.4 Organic Acids
  • 3.1.5 Phytogenics
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Broilers
  • 4.1.3 Breeders and Layers
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Evonik
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Trouw Nutrition
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 DSM
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Alltech
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Novonesis
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bluestar Adisseo
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Eastman
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cargill
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Kemin Industries
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Perstorp
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Novus International
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Orffa
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Merck Animal Health
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Danisco Animal Nutrition & Health (IFF)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Lallemand
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 EW Nutrition
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Balchem
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Impextraco
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Alivira Animal Health
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Biochem
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Biorigin
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Asahi Biocycle
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Amlan International
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 AB Vista
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Lesaffre
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Poultry Gut Health Solutions market?
The global Poultry Gut Health Solutions market is estimated at US$ 5.49 billion in 2025 (base year) and is projected to reach US$ 9.75 billion by 2032.
What is the forecast CAGR for the Poultry Gut Health Solutions market?
The market is expected to grow at a CAGR of 8.7% from 2026 to 2032, expanding from US$ 5.49 billion in 2025 to US$ 9.75 billion in 2032, roughly 1.8 times its base-year value.
What is Poultry Gut Health Solutions?
Poultry Gut Health Solutions refer to a set of products, techniques, and management practices aimed at promoting and maintaining the health and functionality of the gastrointestinal (GI) tract in poultry, such as chickens, turkeys, and ducks. These solutions are crucial for enhancing digestion, nutrient absorption, immune function, and overall growth performance in poultry.
How is the Poultry Gut Health Solutions market segmented by type?
By type, the market is segmented into Probiotics and Prebiotics, Enzymes, Organic Acids, Phytogenics and Others.
What are the key applications of Poultry Gut Health Solutions?
Key applications covered include Broilers, Breeders and Layers and Others.
Which companies are profiled in the Poultry Gut Health Solutions market report?
Key players profiled include Evonik, Trouw Nutrition, DSM, Alltech, Novonesis, Bluestar Adisseo, Eastman and Cargill, among 25 companies covered in total.
What geographies does the Poultry Gut Health Solutions market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Poultry Gut Health Solutions?
In recent years, the poultry industry has experienced significant changes driven by genetic improvements in poultry breeds and fluctuations in feed ingredient prices.
What are the main risks and barriers in the Poultry Gut Health Solutions market?
However, the transition to ABF production poses challenges, primarily due to increased gut health issues that can negatively impact poultry performance.
Who should buy the Poultry Gut Health Solutions market report?
The report is intended for manufacturers and solution providers, distributors and end users in Broilers, Breeders and Layers and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Poultry Gut Health Solutions market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.